CLS Celestica Inc. Earnings Beat: Q2 2026 EPS Tops Estimates

Celestica Inc. (CLS) delivered a mixed earnings report on April 27, 2026. The hardware and supply chain solutions company beat earnings per share expectations but fell slightly short on revenue. CLS reported EPS of $2.16, exceeding the $2.08 estimate by 3.85%. However, revenue came in at $3.96 billion, missing the $3.97 billion forecast by 0.33%. Despite the EPS beat, the stock declined sharply, falling 14.3% in trading. Meyka AI rates CLS with a grade of B+, reflecting mixed fundamentals and valuation concerns.

Celestica Earnings Beat: Strong EPS, Weak Revenue

Celestica delivered solid earnings per share growth but stumbled on the top line. The company posted EPS of $2.16, beating analyst estimates of $2.08 by $0.08 or 3.85%. This marks the third consecutive quarter of EPS beats for the Toronto-based manufacturer.

EPS Performance Trend

Celestika has shown consistent earnings strength across recent quarters. In Q1 2026, the company reported $1.87 EPS versus $1.74 expected. Q3 2025 saw $1.39 actual versus $1.24 estimated. The current quarter’s $2.16 result represents the highest EPS in this four-quarter cycle, demonstrating improving profitability despite market headwinds.

Revenue Miss Signals Demand Weakness

Revenue of $3.96 billion fell short of the $3.97 billion consensus by $13 million or 0.33%. While the miss was modest, it contrasts with stronger revenue beats in prior quarters. Q1 2026 revenue hit $3.61 billion versus $3.49 billion expected. This suggests potential softening in customer demand or supply chain normalization after pandemic-era strength.

Stock Price Reaction and Market Sentiment

The market responded negatively to Celestica’s mixed results, sending shares down sharply despite the EPS beat. This reaction reflects investor concerns about revenue growth and valuation multiples.

Post-Earnings Decline

CLS stock fell 14.3% following the earnings announcement, dropping $60.50 to close at $361.71. The decline pushed the stock below its 50-day moving average of $308.08 and well below the 52-week high of $423.25. Trading volume surged to 5.45 million shares, more than double the average daily volume of 2.37 million, indicating significant investor repositioning.

Valuation Concerns

The stock’s sharp decline despite an EPS beat reflects concerns about valuation and growth prospects. CLS trades at a P/E ratio of 43.95, well above historical norms. Analyst consensus remains bullish with 14 buy ratings versus 7 holds, but the stock’s technical indicators show overbought conditions with RSI at 76.54.

Quarterly Performance Comparison and Trends

Celestica’s earnings trajectory shows improving profitability but mixed revenue dynamics. Comparing the last four quarters reveals important trends about the company’s operational momentum.

EPS Growth Acceleration

EPS has grown consistently: Q3 2025 ($1.39), Q1 2026 ($1.87), and now Q2 2026 ($2.16). This represents 55% growth over two quarters, driven by operational leverage and margin expansion. The company’s net profit margin of 6.7% reflects improving efficiency in manufacturing and supply chain operations.

Revenue Volatility

Revenue shows less consistent growth. Q3 2025 hit $2.89 billion, Q1 2026 reached $3.61 billion, and Q2 2026 came in at $3.96 billion. While the trend is upward, the modest revenue miss this quarter suggests growth may be moderating. The company’s gross profit margin of 11.6% indicates stable pricing power despite competitive pressures in hardware manufacturing.

What This Means for Celestica Investors

The earnings report presents a complex picture for CLS shareholders. Strong EPS growth is offset by revenue concerns and elevated valuation multiples that leave little room for disappointment.

Profitability Strength

Celestica’s ability to beat EPS estimates three quarters running demonstrates operational excellence. The company is converting revenue into earnings efficiently, with operating margins of 7.6%. This suggests management is executing well on cost control and operational improvements despite supply chain challenges.

Growth Headwinds

The revenue miss, though small, signals potential demand softening. With a price-to-sales ratio of 3.88 and enterprise value-to-sales of 3.93, the stock offers limited margin of safety. Investors are pricing in significant future growth that may not materialize if revenue growth continues to decelerate.

Forward Outlook

Meyka AI’s B+ grade reflects neutral fundamentals with mixed signals. Strong ROE of 44.1% and ROA of 11.6% show efficient capital deployment. However, the elevated P/E of 43.95 and debt-to-equity ratio of 0.41 suggest the stock is fairly valued at best. Investors should monitor Q3 2026 results for evidence of sustained revenue growth.

Final Thoughts

Celestica beat EPS estimates for the third consecutive quarter but missed on revenue, signaling potential demand softening. The 14.3% stock decline despite the earnings beat reflects investor concerns about growth sustainability and valuation. With a P/E ratio of 43.95, the stock appears fairly valued with limited upside unless revenue accelerates. Investors should monitor forward guidance and Q3 results to determine if this represents a temporary pause or the beginning of growth deceleration.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.